NationalSerum Institute Defends Covishield Pricing, Says ‘Inaccurate Comparison’BY Outlook Web Bureau
National21,000 People Contracted Covid-19 After Receiving First Dose Of Vaccine: CentreBY Outlook Web Bureau
NationalCovid-19 Vaccine Crunch: Nepal Requests India To Facilitate Supply Of JabsBY Outlook Web Bureau
NationalMadhya Pradesh: Doctor Tests Positive For Covid-19 After Second Dose Of VaccineBY Outlook Web Bureau
NationalPeople Who Recovered From Covid-19 Show Faster Antibody Response To Covishield Vaccine: StudyBY Outlook Web Bureau
National'Serum Institute Directed To Prioritise India Needs', Adar Poonawalla Asks World To Be PatientBY Outlook Web Bureau
NationalBreather For Serum Institute As Court Rejects Trademark-Violation Plea Against `Covishield'BY Outlook Web Bureau
NationalA Shot At Freedom: Making Of The Vaccine Inside Serum Institute Of India, PuneBY Outlook Web Desk
_.jpg?auto=format%2Ccompress&fit=max&format=webp&w=300&dpr=1.0)
_570_850.png?auto=format%2Ccompress&fit=max&format=webp&w=300&dpr=1.0)
